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reported in China [5]. Both scenarios could lead to the
rapid spread, to and among animals, of MRSA strains that
are capable of causing severe skin and soft tissue infection
in healthy human populations.
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Abstract
The spread of plasmid-mediated quinolone resistance determi-
nants (qnr-like determinants, aac(6¢)-Ib-cr and qepA genes) was
evaluated in a collection of 281 nalidixic acid-resistant enterobac-
terial isolates recovered between September 2005 and Decem-
ber 2007 at the Sahloul Hospital, Sousse, Tunisia. Sixteen percent
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of those isolates carried qnr genes encoding the QnrB1, QnrB2,
QnrA6 or QnrS1 determinants. Most qnr-positive isolates were
extended-spectrum ß-lactamase (ESBL) producers, being pre-
dominantly of the CTX-M-15 type, but also of the SHV-28 and
SHV-12 types. The qnr genes were located on plasmids with a
size in the range 55–150 kb. The qnrB2 gene was associated with
sul1-type integron structures and the qnrB1 gene was associated
with orf1005, whereas the genetic environment of qnrA6 was
unknown. In two isolates, the qnrS1 gene was located down-
stream of an ISEcl2 element on plasmids that often carried the
narrow-spectrum ß-lactamase gene blaLAP-2; qepA and aac(6¢)-Ib-cr
were not detected. The present study highlights the wide spread
of Qnr-like determinants in Tunisia, with an association with the
ESBL CTX-M-15 in human clinical isolates.
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Recently, three transferable quinolone resistance mechanisms
have been described: (i) a target-protective mechanism
encoded by the qnr genes [1]; (ii) a dual antibiotic-modifying
enzyme that acetylates aminoglycosides, but also ciproﬂoxa-
cin and norﬂoxacin encoded by the aac(6¢)-Ib-cr gene [2]; and
(iii) an efﬂux pump encoded by the qepA gene [3]. The qnr
genes encode pentapeptide repeat proteins that protect the
DNA gyrase and topoisomerases IV from quinolone binding,
thereby reducing the susceptibility to nalidixic acid and ﬂuor-
oquinolones [4]. Five types of Qnr determinants have been
described in Enterobacteriaceae, which are encoded by the
qnrA, qnrB, qnrC, qnrD and qnrS genes [5–8]. The qnrA genes
are usually located on complex sul1-type class 1 integrons
[9]. The qnrB genes are either associated with sul1-type
integron structures, a speciﬁc orf1005 or the insertion
sequence ISEcp1 [10,11]. The qnrS1 gene has always been
identiﬁed in association with ISEcl2, whereas qnrS2 has been
identiﬁed in very peculiar mobile insertion cassette struc-
tures [12,13].
In the present study, we investigated the prevalence of
plasmid-mediated quinolone resistance determinants among a
collection of extended-spectrum ß-lactamase (ESBL)- and
non-ESBL-producing enterobacterial isolates, which are all
resistant to nalidixic acid, and which were isolated at Sahloul
Hospital, Sousse, Tunisia, from September 2005 to Decem-
ber 2007. A total of 1705 nonrepetitive enterobacterial iso-
lates were recovered during the study period. Among them,
580 (34%) isolates were resistant to nalidixic acid, of which
281 (approximately half of that collection) were available and
retained for study, and among which 196 (70%) were pro-
ducing an ESBL. The species distribution comprised: Klebsiella
pneumoniae (n = 130), Escherichia coli (n = 85), Enterobacter
cloacae (n = 36), Morganella morganii (n = 10), Citrobacter
freundii (n = 8), Proteus mirabilis (n = 6), Klebsiella oxytoca
(n = 5) and Providencia stuartii (n = 3). The qnrA, qnrB and
qnrS genes (the qnrC and qnrD genes were not known at the
time of the study) were screened for by a multiplex PCR-
based technique as described previously [14]. The search
for the qepA gene was performed using primers QepA-F
(5¢-CGTGTTGCTGGAGTTCTTC-3¢) and QepA-R (5¢-CTG
CAGGTACTGCGTCATG-3¢), amplifying a 403-bp fragment.
The presence of the ac(6¢)-Ib gene was detected only among
the qnr-positive isolates by using primers AAC6¢-A (5¢-
TTGCGATGTCTATGAGTGGTA-3¢) and AAC6¢-B (5¢-
CTCGAATGCCTGGCGTGTTT-3¢) to produce a 482-bp
product [13]. The corresponding amplicons were subse-
quently sequenced to identify the aac(6¢)-Ib-cr variant. The
blaTEM, blaSHV and blaCTX-M genes were searched for by PCR
among all qnr-positive isolates using speciﬁc primers, as pre-
viously reported [9,15], and were further identiﬁed by
sequencing. Among 281 nalidixic acid-resistant isolates, 45
were found to be qnr-positive (16%). Seven out of these 45
isolates (15%) were qnrS-positive, 12 (27%) were qnrA-posi-
tive and 26 (58%) were qnrB-positive. Sequencing of the two
former led to the identiﬁcation of only qnrS1 and qnrA6
alleles. Among the 26 qnrB-positive isolates, 15 were qnrB1
and 11 were qnrB2. The qnrB gene was more prevalent
among E. cloacae isolates, whereas qnrA was more prevalent
among K. pneumoniae isolates. Overall, the qnrB gene was the
most prevalent compared to the qnrA and qnrS genes. This
result agrees with the most recent studies indicating that
QnrA, although representing the Qnr determinant identiﬁed
initially, is not the most prevalent Qnr determinant world-
wide [5,14,15]. This is also in accordance with the only
published study of the Qnr prevalence in the Maghreb, which
reported QnrB1, QnrB4 and QnrS1 in E. cloacae from
Algeria [16].
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TABLE 1. Features of the QnrA-, QnrB- and QnrS-positive enterobacterial isolates
Isolate
Date of
isolation
(mm/dd/yy) Specimen
Hospitalization
unit
Qnr
Determinant/
ß-lactamase(s)
Plasmid
size (kb)a
Associated non ß-lactam antibiotic
resistance markersb
Klebsiella pneumoniae 13 05/20/06 Blood ICU QnrA6
SHV-28
120 GEN AMK NET TOB KAN TMP RIF CHL TET
Klebsiella pneumoniae 59 06/25/06 Urine Urology QnrA6
SHV-28, TEM-1
120 GEN AMK NET TOB KAN TMP RIF TET
Klebsiella pneumoniae 3 07/04/06 Urine ICU QnrA 6
CTX-M-15
120 GEN AMK NET TOB KAN TMP RIF CHL
Klebsiella pneumoniae 9 02/12/07 Urine ICU QnrA6 CTX-M-15, TEM-1 120 TOB KAN TET
Klebsiella pneumoniae 21 06/19/07 Urine ICU QnrA6
SHV-28
120 GEN AMK NET TOB KAN TMP RIF CHL
Klebsiella pneumoniae 36 11/17/07 Blood Urology QnrA6
SHV-28, TEM-1
120 GEN AMK NET TOB KAN TMP RIF CHL
Citrobacter freundii 2 06/02/06 Urine ICU QnrA6 120 GEN AMK TOB KAN TMP RIF CHL TET
Proteus mirabilis 4 10/13/06 Urine Urology QnrA6 55 GEN AMK NET TOB KAN TMP RIF CHL TET
Proteus mirabilis 1 01/16/07 Blood ICU QnrA6 TEM-1 120 AMK NET TOB KAN TMP RIF CHL TET
Proteus mirabilis 3 09/22/07 Blood ICU QnrA6 120 GEN AMK NET TOB KAN TMP RIF CHLTET
Providencia stuartii 3 09/12/06 Blood ICU QnrA6 120 GEN AMK NET TOB KAN TMP RIF CHL TET
Providencia stuartii 2 09/27/06 Blood ICU QnrA6 55 NET TOB KAN TMP RIF CHL TET
Klebsiella pneumoniae 39 07/27/06 Blood ICU QnrB1
CTX-M-15, SHV-28, TEM-1
125 GEN AMK NET TOB KAN TMP RIF TET
Klebsiella pneumoniae 4 09/02/06 Urine Urology QnrB1 60 AMK TMP RIF CHL
Escherichia coli 17 02/06/06 Urine Urology QnrB1
CTX-M-15, TEM-1
66 GEN NET TOB KAN TMP RIF CHL TET
Escherichia coli 11 07/07/06 Urine Paediatric QnrB1
CTX-M-15, TEM-1
80 GEN TOB KAN TMP RIF CHL TET
Escherichia coli 6 07/27/06 Urine Paediatric QnrB1
CTX-M-15, TEM-1
80 NET TOB KAN TMP RIF CHL TET
Escherichia coli 2 08/07/06 Urine Paediatric QnrB1 CTX-M-15, TEM-1 80 GEN TOB KAN TMP CHL TET
Enterobacter cloacae 31 (PII) 12/29/05 Urine Urology QnrB1
CTX-M-15, TEM-1
150 GEN TOB KAN TMP RIF CHL TET
Enterobacter cloacae 33 (PI) 05/02/06 Urine ICU QnrB1
CTX-M-15
120 GEN AMK NET TOB KAN TMP RIF CHL TET
Enterobacter cloacae 10 (PI) 10/09/06 Urine Urology QnrB1
CTX-M-15, TEM-1
60 GEN TOB KAN NET TMP CHL TET RIF
Enterobacter cloacae 8 (PI) 01/27/07 Urine Urology QnrB1
CTX-M-15, TEM-1
60 GEN TOB KAN NET TMP CHL TET RIF
Enterobacter cloacae 6 (PI) 01/29/07 Blood Urology QnrB1
CTX-M-15, TEM-1
60 GEN TOB KAN NET TMP CHL TET RIF
Enterobacter cloacae 2 (PI) 05/21/07 Urine ICU QnrB1
CTX-M-15, TEM-1
60 GEN TOB KAN NET TMP CHL TET RIF
Enterobacter cloacae 14 (PI) 09/21/07 Blood ICU QnrB1
CTX-M-15, TEM-1
60 GEN TOB KAN NET TMP CHL TET RIF
Enterobacter cloacae 13 (PI) 10/08/07 Blood ICU QnrB1
CTX-M-15, TEM-1
60 GEN TOB KAN TMP RIF CHL TET
Citrobacter freundii 1 10/07/05 Urine Urology QnrB1 100 GEN NET TOB KAN TMP RIF CHL TET
Klebsiella pneumoniae 7 05/31/07 Blood ICU QnrB2
CTXM-15, SHV-28, TEM-1
120 GEN NET TOB KAN TMP RIF L TET
Klebsiella oxytoca 1 04/08/06 Urine Urology QnrB2 100 GEN NET TOB KAN TMP RIF L TET
Escherichia coli 5 01/16/06 Urine Urology QnrB2 TEM-1 60 KAN TMP RIF TET NET
Escherichia coli 1 02/06/06 Urine Urology QnrB2
CTX-M-15, TEM-1
120 GEN TOB KAN TMP RIF CHL TET
Escherichia coli 3 03/22/07 Urine Urology QnrB2 55 GEN AMK NET TOB KAN RIF CHL TET
Enterobacter cloacae 9 (PII) 12/03/05 Urine Urology QnrB2
SHV-12, TEM-1
150 GEN TOB KAN TMP RIF CHL TET
Enterobacter cloacae 1 (PIII) 07/07/06 Urine Paediatric QnrB2
SHV-12 TEM-1
150 GEN TOB KAN TMP RIF
Enterobacter cloacae 11 (PI) 04/12/07 Blood Paediatric QnrB2
CTX-M-15, TEM-1
65 GEN NET TOB KAN TMP RIF CHL TET
Enterobacter cloacae 15 (PI) 11/08/07 Blood ICU QnrB2
CTX-M-15, TEM-1
65 GEN NET TOB KAN TMP RIF C TET
Citrobacter freundii 4 12/17/05 Urine Urology QnrB2
CTX-M-15, TEM-1
120 TOB KAN TMP RIF TET
Citrobacter freundii 3 12/29/06 Urine ICU QnrB2
SHV-2a, TEM-1
150 GEN NET TOB KAN TMP RIF CHL TET
Klebsiella pneumoniae 1 12/20/06 Blood Paediatric QnrS1
LAP-2
100 NET RIF CHL TET
Klebsiella pneumoniae 6 05/07/07 Urine Urology QnrS1
TEM-1
100 TMP RIF
Escherichia coli 38 10/30/05 Urine Urology QnrS1
CTX-M-15, TEM-1
80 GEN NET TOB KAN TMP RIF
Escherichia coli 39 01/09/06 Urine Urology QnrS1
CTX-M-15, TEM-1
80 TOB KAN TET
Enterobacter cloacae 19 05/22/06 Blood Urology QnrS1
CTX-M-15, LAP-2
120 TMP RIF TET
Enterobacter cloacae 4 11/01/06 Blood ICU QnrS1
CTX-M-15, TEM-1
80 GEN AMK NET TOB KAN TMP RIF
Enterobacter cloacae 22 11/14/07 Urine Urology QnrS1
CTX-M-15, LAP-2
120 NET RIF TET
Sizes of the plasmids harbouring the qnrA6, qnrB1, qnrB2 or qnrS1 genes and associated non ß-lactam antibiotic resistance markers.
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Twenty-eight qnr-positive, ESBL-producing isolates were
detected, further underlining the frequent association
between qnr and ESBL genes, as previously demonstrated
[8,17]. The CTX-M-15 determinant was identiﬁed in 19 qnr-
positive isolates, whereas six isolates produced SHV-28, two
produced SHV-12 and one produced SHV-2a. The gene
encoding the narrow-spectrum b-lactamase TEM-1 was
detected in 64% of the qnr-positive isolates. The clinical fea-
tures of the qnr-positive isolates and their distribution among
species are indicated in Table 1. All qnr-positive isolates har-
boured the aac(6¢)-Ib gene, but sequencing did not reveal the
aac(6¢)-Ib-cr gene. The search for qepA remained negative for
all isolates.
Clonal relatedness among the qnr-positive isolates was
evaluated by Rep-PCR for E. coli and ERIC-2 for non E. coli
isolates, as described previously [18]. Many isolates exhibited
different DNA patterns, indicating that they were not clon-
ally related. However, E. cloacae isolates carrying qnrB genes
showed three major patterns, namely PI (nine isolates), PII
(two isolates) and PIII (one isolate). In addition, the six
K. pneumoniae isolates harbouring the qnrA6 gene were clon-
ally related (data not shown). These results demonstrated
that the occurrence of qnr genes was related to the dissemi-
nation, at the same time, of some speciﬁc isolates and of
clonally unrelated isolates.
Electrophoresis of the plasmid extract, followed by South-
ern hybridization, as described previously [9] showed that
the qnr genes were located on plasmids with sizes in the
range of 55–150 kb. All qnrA6-positive plasmids identiﬁed
among the clonally related K. pneumoniae isolates, but also
among the other qnrA6-positive enterobacterial isolates were
120 kb in size, suggesting the diffusion of a single plasmid.
The clonally related qnrB1-positive E. cloacae isolates exhibit-
ing pattern PI carried a 60-kb plasmid and expressed the
ESBL CTX-M-15 together with b-lactamase TEM-1, with the
exception of E. cloacae 33, which carried a 120-kb qnrB1-
positive plasmid encoding CTX-M-15 only. The qnrS1-carry-
ing plasmids differed in size, in the range of 80–120 kb. The
corresponding isolates all produced the ESBL CTX-M-15,
whereas some produced additionally the narrow-spectrum
ß-lactamase LAP-2 [19].
Genetic structures surrounding the qnrA, qnrB and qnrS
genes were detected by PCR mapping using different primer
sets, as described previously [9,12]. The qnrB2 gene was sys-
tematically associated with the ISCR1 element embedded in a
sul1-type integron. The qnrB1 gene was always found down-
stream of orf1005, as described previously [10]. The ISCR1
element was not identiﬁed in the qnrA6 vicinity, although it is
usually identiﬁed in association with qnrA. The blaLAP-2 gene
was identiﬁed upstream of qnrS1 in one K. pneumoniae (iso-
late 1) and in two E. cloacae (isolates 19 and 22), with both
genes being separated by the insertion sequence ISEcl2 [20].
PCR mapping revealed that ISEcl2 and blaLAP-2 were absent
upstream of qnrS1 in K. pneumoniae 1, K. pneumoniae 6,
E. coli 38, E. coli 39, and E. cloacae 4 isolates.
The present study revealed quite a high prevalence of plas-
mid-borne quinolone resistance determinants among nalidixic
acid-resistant enterobacterial isolates recovered in a Tunisian
hospital. It allowed us to conclude that small-scale outbreaks
had occurred in this hospital and it is the ﬁrst study to focus
on the epidemiology of plasmid-borne quinolone resistance
determinants among clinical isolates in Tunisia.
Finally, the present study further indicates that the most
prevalent ESBL in this region is CTX-M-15, as is the case in
many parts of the world.
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Abstract
Djibouti is an East African country with a high tuberculosis
incidence. This study was conducted over a 2-month period in
Djibouti, during which 62 consecutive patients with pulmonary
tuberculosis (TB) were included. Genetic characterization of
Mycobacterium tuberculosis, using mycobacterial interspersed
repetitive-unit variable-number tandem-repeat typing and spoli-
gotyping, was performed. The genetic and phylogenetic analysis
revealed only three major families (Central Asian, East African
Indian and T). The high diversity and linkage disequilibrium
within each family suggest a long period of clonal evolution. A
Bayesian approach shows that the phylogenetic structure
observed in our sample of 62 isolates is very likely to be repre-
sentative of the phylogenetic structure of the M. tuberculosis
population in the total number of TB cases.
Keywords: Djibouti, genetic diversity, Mycobacterium tuberculosis,
population structure, spoligotyping/MIRU-VNTR
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Djibouti is an East African country with a total population of
over 819 000. In 2004, the estimated tuberculosis (TB) inci-
dence was 951 cases per 100 000 inhabitants, which is one
of the highest incidences in the world [1]. The objectives of
this study were to identify the Mycobacterium tuberculosis
families responsible for the TB cases, and to analyse their
genetic diversity and the structure of the M. tuberculosis
population in an area with this high TB incidence.
The study was conducted over a 2-month period at Paul
Faure Hospital in Djibouti City. During this period, 62 consec-
utive patients with symptomatic disease and sputum culture
positive for M. tuberculosis complex were included. Spoligotyp-
ing [2] and mycobacterial interspersed repetitive-unit variable-
number tandem-repeat (MIRU-VNTR) typing [3] was
performed with DNA from each isolate. To study the genetic
variability, a set of diversity indices, including genotypic
diversity and mean genetic diversity (H), was evaluated using
F-STAT version 2.9.3 [4]. The population structure was
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